Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
August 19, 2021
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with NSCLC – – Study to be presented September 13 at IASLC 2021 World Conference on Lung Cancer – SHANGHAI, China, and REDWOOD CITY, Calif., […]